Previous 10 | Next 10 |
home / stock / prn:cc / prn:cc news
2024-01-16 16:35:19 ET More on Profound Medical Profound Medical lays out Q4 and FY 2024 preliminary numbers Profound Medical sells 2.67M shares at $7.50 in public offering For further details see: Profound Medical announces $2.94M non-brokered private placement
2024-01-04 03:31:30 ET More on Profound Medical Profound Medical sells 2.67M shares at $7.50 in public offering Biggest stock movers today: Sociedad Quimica Y Minera de Chile, Profound Medical and more Seeking Alpha’s Quant Rating on Profound Medical F...
TORONTO, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, to...
2023-12-28 09:54:35 ET More on Profound Medical Profound Medical Corp. (PROF) Q3 2023 Earnings Call Transcript Biggest stock movers today: Sociedad Quimica Y Minera de Chile, Profound Medical and more Profound Medical stock sinks on proposed public offering of common...
2023-12-28 08:51:19 ET Bluejay Diagnostics ( BJDX ) -36% on pricing of $3.5 million stock offering . Cytosorbents CTSO -29% as blood purification system fails key trial . First Wave BioPharma ( FWBI ) -17% . NKGen Biotech ( NKGN ) -12% . ...
TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“ Profound ” or the “ Company ”) today announced the pricing of its previously announced underwritten public offering (the “ Offering ”) of 2,666,667 com...
2023-12-27 16:25:29 ET More on Profound Medical Profound Medical Corp. (PROF) Q3 2023 Earnings Call Transcript Stifel starts coverage of Profound Medical with hold rating Seeking Alpha’s Quant Rating on Profound Medical Historical earnings data for Pro...
TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“ Profound ” or the “ Company ”) is pleased to announce the commencement of an underwritten public offering in the United States of common shares (the “ Common Sh...
2023-12-01 15:27:39 ET More on Profound Medical Profound Medical Corp. (PROF) Q3 2023 Earnings Call Transcript Profound Medical receives FDA 510(k) clearance for TULSA-PRO Thermal Boost Profound Medical gains as investment bank Raymond James raises rating to Strong B...
TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, to...
News, Short Squeeze, Breakout and More Instantly...
Profound Medical Corp. Company Name:
PRN:CC Stock Symbol:
TSXC Market:
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the voting results from its Annual General Meeting of Shareholders that was held today (the “Meeting”). A total ...
PROFOUND MEDICAL ANNUAL GENERAL MEETING OF SHAREHOLDERS VOTING RESULTS Canada NewsWire TORONTO , May 15, 2024 /CNW/ - Profound Medical Corp. (TSX: PRN) (NASDAQ: PROF) ("Profound" or the "Company") is pleased to announce the voting results from its Annual General ...
– Prostate segmentation using a deep learning convolutional neural network – – Model uses 24,611,072 parameters extracted from 7,466 training images – – Validated in standalone and multi-reader, multi-case clinical studies conducted by world-reno...